Bioluminescence imaging of MM-bearing mice revealed the BCMA–CST6–CAR-T cells were effective in terms of antitumor activity, yielding near-complete tumor clearance by day 21, whereas myeloma cells continued to grow in the MOCK–CAR-T group. This evidence concerns the gene TNFRSF17 and plasma cell myeloma.